Justin Meiklem

Vancouver, British Columbia and Rehovot, Israel – February 12, 2025 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the WeBull Consumer Stocks Virtual Webinar taking place on February 18, 2025.

Vancouver, British Columbia and Rehovot, Israel – February 10, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that that it has applied and received approval for a voluntary delisting of its common shares from the Canadian Securities Exchange (“CSE”). The

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel – January 22, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that Mr. Sharon Malka has agreed to serve

Vancouver, British Columbia and Rehovot, Israel – January 8, 2025– BioHarvest Sciences Inc., (Nasdaq: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2024 can be summarized as a year

   New collaboration to pioneer next generation of plant-based ingredients for healthier food and beverages        December 11, 2024 – London, UK and Vancouver, Canada – Tate & Lyle PLC(‘Tate & Lyle’), a world leader in ingredient solutions for healthier and tastier food and beverages, and BioHarvest Sciences (NASDAQ:BHST) (CSE:BHSC) (‘BioHarvest’), leaders in Botanical Synthesis, announce

Third Quarter 2024 Revenue Increased 101% Year-over-Year to Over $6.5 Million, Exceeding Management Guidance Vancouver, British Columbia and Rehovot, Israel – November 25, 2024 – BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for